GMP Validated Next Generation Sequencing Services

Viral Safety Testing & Genetic Characterization

Traditional sequencing methods can be limited in what they can offer if samples are not pure or if they cannot be cultured, if they fail to generate usable data, or if the target DNA is large (multiple kilobases or genome-sized) making the traditional methods complex, expensive, and time consuming.

Discover Accugenix® Next Generation Sequencing for bacterial identification and fungal ID, a technology that enables high throughput, scalability and novel applications.

Our Technology and Market Development team has polled our QC pharmaceutical customers, and the top requests were the following:

  • Expeditious and accurate results when investigating contamination events, so the customer may reduce downtime and uncertainty
  • Deeper technical partnerships, with proven professionals who can offer support in contamination identification and response strategy, so effective meaningful action may be taken
  • Single vendor management so the customer may manage their POs, experience dedicated customer service, and reduce administrative “busy-work” to focus on delivering results




Fill out the details below

I want to receive follow-up communications from The Medicine Maker and its sponsors. I understand that I can unsubscribe at any time.
Charles River Labaratory would like to contact you in the future on their products and services via phone, email, and/or post. For more details on our information practices and how to unsubscribe, please see their Privacy Policy. You can unsubscribe at any time.
I want to receive follow-up communications from The Medicine Maker and its sponsors. I understand that I can unsubscribe at any time.
If you engage with the content, EnterpriseGuide will share your data with Charles River Labaratory. For details on their information practices and how to unsubscribe, see their Privacy Policy. You can unsubscribe at any time.
You have been directed to this site by Enterprise Guide. For more details on our information practices, please see our Privacy Policy, and by accessing this content you agree to our Terms of Use. You can unsubscribe at any time.